AHCY Gene Mutation: Symptoms, Supplements & Treatment

Key Takeaways

• AHCY encodes S-adenosylhomocysteine hydrolase, which converts SAH to homocysteine and adenosine, maintaining methylation balance.
• AHCY deficiency is marked by elevated levels of SAH and S-adenosylmethionine (SAM), which may lead to neurological and muscular issues. 
•  Diagnosis is linked to biochemical tests and genetic testing of the AHCY gene.
•  Treatment may include dietary methionine restrictions and nutritional support with vitamins to aid metabolism.
• Patient outcomes may vary, necessitating personalised management.  

What Is the AHCY Gene?

Adenosylhomocysteinase (AHCY) is among the most conserved proteins across various organisms.1 This gene contains information for the s-adenosylhomocysteine hydrolase enzyme that facilitates the conversion of S-adenosylhomocysteine (SAH) into adenosine and homocysteine. 

The AHCY gene is linked to the regulation of one-carbon and methionine metabolism pathways. AHCY gene mutations follow an autosomal recessive pattern of inheritance. 

Alterations in the AHCY gene may affect s-adenosylhomocysteine hydrolase function, leading to reduced enzyme activity.2

What Is the Role of the AHCY Gene in Methionine Metabolism and Methylation?

Human S-adenosylhomocysteine hydrolase, the product of the AHCY gene, is crucial for cellular processes. S-adenosylhomocysteine hydrolase deficiency impairs the methionine cycle.

 The AHCY enzyme catalyzes the breakdown of SAH to homocysteine and adenosine.1 The SAM: SAH ratio, called the methylation index, reflects the cell’s capacity for methylation. 

The accumulation of S-adenosylhomocysteine (SAH) due to a deficiency in the AHCY enzyme leads to various health issues: SAH cannot be broken down, which inhibits methyltransferases and impairs methylation of DNA, RNA, proteins, and lipids; this, in turn, causes hypermethioninemia, which further contributes to systemic health problems.6 

What Causes AHCY Deficiency? What is its genetic basis?

AHCY deficiency is a rare autosomal recessive genetic disorder caused by pathogenic mutations in the AHCY gene.4,7 

AHCY gene mutation of more than 10 distinct types has been documented. These AHCY mutations include missense variants and nonsense mutations.

When enzyme activity is drastically reduced, sometimes to 3% of normal, the conversion of S-adenosylhomocysteine to adenosine and homocysteine is impaired. This results in marked accumulation of SAH and SAM. 

The disorder affecting methionine metabolism can lead to hypermethioninemia, though methionine levels may be normal at an early stage.2

What are the common AHCY variants?

AHCY gene mutation may affect the function of the S-adenosylhomocysteine hydrolase enzyme. G274A (rs41301825) is a missense variant. The rare ‘A’ allele is linked to the reduced AHCY enzyme activity.5

G123A alters the enzyme similarly. It lowers activity without known symptoms. C112T (rs13043752) is another missense change. 

Trp38 allozyme (encoded by this variant) showed a slight but significant decrease in AHCY activity to 73.6% of wild-type enzyme activity when measured in mammalian cell expression systems.

A38T (possibly rs41312290, A to G) shows no reduction in activity in studies. 12,13

What Are the Symptoms of AHCY Gene Mutations and Their Information on Health Impacts?

Hypermethioninemia with AHCY deficiency may manifest across a spectrum from asymptomatic cases to those with more severe symptoms. 

Neurological symptoms may include psychomotor delays, microcephaly, intellectual challenges, changes in behaviour, and occasionally seizures.2

Muscular manifestations may indicate muscle stress. There may be a progression of muscle weakness that can influence mobility and functional abilities.3

Elevated liver enzymes and irregular coagulation patterns may suggest hepatic dysfunction.3

How Is AHCY Gene Deficiency Diagnosed and their Information Tested Genetically?

Diagnostic suspicion arises when newborn screening detects elevated methionine or when symptoms may indicate metabolic disease. 

Biochemical Testing: Hypermethioninemia with S-adenosylhomocysteine accumulation is a hallmark, characterised by markedly elevated plasma levels of SAH and SAM. Analysis of DNA methylation information may reveal hypermethylation patterns.10 

Genetic Testing: Definitive diagnosis involves sequencing of the AHCY gene using Sanger sequencing or next-generation sequencing (NGS). Genetic analysis typically reveals two mutations—one altered gene from each parent. 9

What Are the Treatment Options and Nutritional Support Information for AHCY Gene Mutations?

AHCY deficiency lacks a cure, but medical treatment focuses on managing metabolic disruption through dietary and nutritional strategies, which may support long-term health outcomes.

Dietary Management  

A methionine-restricted diet is linked to the primary treatment approach. By limiting dietary methionine, the accumulation of SAM and SAH may be reduced, though complete normalisation is rarely possible.4, 8

Nutrition and Lifestyle Support

Nutritional strategies may enhance treatment. Supplementation with these nutrients may improve clinical outcomes in some patients. (link: Nutrigenomics) 

• Folate-rich foods, such as spinach, asparagus, and lentils, boost intake. Brussels sprouts and leafy greens are high in them. Chickpeas and eggs add variety.​
• Hydration maintains metabolic flow. It may be advised to drink adequate water daily. Moderate protein intake limits methionine.​
• Lifestyle tips involve monitoring. Regular check-ups track progress. 
• Exercise builds strength gently. Stress management aids neurological health.​ 11

Caution with SAMe and Methylation Supplements

SAMe supplements require care in AHCY deficiency. They may worsen SAH buildup. Excess SAMe disrupts rhythms and inhibits methylation.​

Avoid overuse of methyl donors. High doses can imbalance the SAM: SAH ratio. Consult professionals before starting. Personalized plans prevent risks.​14

How does DNA methylation affect gene expression in AHCY deficiency?

AHCY deficiency disrupts DNA patterns, altering gene expression. Affected individuals may show hypermethylation at specific genomic regions, including imprinted genes. (link: DNA Methylation)

What are the current research and clinical insights?

Recent research has helped us in better understanding AHCY deficiency, revealing milder phenotypes, novel variants with ethnic specificity, expanded dysmorphic features, and reversible neurological effects modulated by diet. (link: Genetic Methylation Test) 15, 16   

What are the challenges of living with an AHCY gene mutation, and how can genetic counselling support affected individuals and families?

Living with an AHCY gene mutation requires planning and personalized management to improve quality of life. Families benefit from support networks.​

Genetic counselling explains inheritance patterns in genetics and assesses the risks of being a carrier. Counsellors can help with family planning. Genetic Testing informs offspring’s chances.​

Daily strategies include diet adherence. Monitoring symptoms may prevent complications.​ 17

FAQ

What causes AHCY gene mutations?

AHCY gene mutations are inherited recessively. Pathogenic variants reduce s-adenosylhomocysteine hydrolase activity.​

How does AHCY affect homocysteine levels?

S-adenosylhomocysteine hydrolase deficiency causes SAH buildup, which may lead to hypermethioninemia.​

Are supplements safe for AHCY deficiency?

Folate and B vitamins may help, but excess SAMe should be avoided. Consult a doctor first.​

What is the prognosis for AHCY deficiency?

Outcomes may vary from mild to severe. Early intervention aids better health.

Disclaimer

This article is for educational purposes only and does not constitute medical advice.

References

1. https://pmc.ncbi.nlm.nih.gov/articles/PMC8044520/ 
2. https://medlineplus.gov/genetics/gene/ahcy/#references (National Library of Medicine)
3. https://pubmed.ncbi.nlm.nih.gov/15024124/
4. https://pubmed.ncbi.nlm.nih.gov/35789945/
5. https://pubmed.ncbi.nlm.nih.gov/19619139/
6. https://pubmed.ncbi.nlm.nih.gov/33869213/
7. https://omim.org/entry/613752 
8. https://pmc.ncbi.nlm.nih.gov/articles/PMC9249945/ 
9. https://www.ncbi.nlm.nih.gov/gtr/conditions/C3151058/
10. https://pmc.ncbi.nlm.nih.gov/articles/PMC5203850/ 
11. https://pmc.ncbi.nlm.nih.gov/articles/PMC7551072/
12. https://pmc.ncbi.nlm.nih.gov/articles/PMC2838417/ 
13. https://pubmed.ncbi.nlm.nih.gov/15241484/ 
14. https://pmc.ncbi.nlm.nih.gov/articles/PMC9701592/ 
15. https://pubmed.ncbi.nlm.nih.gov/39634240/ 
16. https://pubmed.ncbi.nlm.nih.gov/39512434/ 
17. https://pmc.ncbi.nlm.nih.gov/articles/PMC2876820/